About this item:

89 Views | 178 Downloads

Author Notes:

Address correspondence to: Ryan P. Barbaro, University of Michigan, 1500 East Medical Center Drive, Mott F-6790/Box 5243, Ann Arbor, MI 48109, barbaror@med.umich.edu, (734) 764-5302.

Drs. Barbaro and Thiagarajan are on the steering committee for the Extracorporeal Life Support Organization.

Dr. Barbaro is the ELSO Registry Chair and Dr. Thiagarajan is the immediate past Registry Chair.

The authors have no other conflicts of interest relevant to this article to disclose.

Subjects:

Research Funding:

Source of Funding: This research did not have funding support.

Keywords:

  • Science & Technology
  • Technology
  • Life Sciences & Biomedicine
  • Engineering, Biomedical
  • Transplantation
  • Engineering
  • extracorporeal membrane oxygenation
  • extracorporeal life support
  • outcomes
  • complications
  • pediatric
  • neonate
  • Extracorporeal Life Support Organization
  • RISK ESTIMATE SCORE
  • MEMBRANE-OXYGENATION
  • INTENSIVE-CARE
  • RESPIRATORY-FAILURE
  • PREDICTING SURVIVAL
  • ACUTE PHYSIOLOGY
  • MORTALITY
  • CHILDREN
  • VALIDATION
  • INDEX

Pediatric Extracorporeal Life Support Organization Registry International Report 2016

Tools:

Journal Title:

ASAIO Journal

Volume:

Volume 63, Number 4

Publisher:

, Pages 456-463

Type of Work:

Article | Post-print: After Peer Review

Abstract:

The purpose of this report is to describe the international growth, outcomes, complications, and technology used in pediatric extracorporeal life support (ECLS) from 2009 to 2015 as reported by participating centers in the Extracorporeal Life Support Organization (ELSO). To date, there are 59,969 children who have received ECLS in the ELSO Registry; among those, 21,907 received ECLS since 2009 with an overall survival to hospital discharge rate of 61%. In 2009, 2,409 ECLS cases were performed at 157 centers. By 2015, that number grew to 2,992 cases in 227 centers, reflecting a 24% increase in patients and 55% growth in centers. ECLS delivered to neonates (0-28 days) for respiratory support was the largest subcategory of ECLS among children <18-years old. Overall, 48% of ECLS was delivered for respiratory support and 52% was for cardiac support or extracorporeal life support to support cardiopulmonary resuscitation (ECPR). During the study period, over half of children were supported on ECLS with centrifugal pumps (51%) and polymethylpentene oxygenators (52%). Adverse events including neurologic events were common during ECLS, a fact that underscores the opportunity and need to promote quality improvement work.

Copyright information:

© 2017 by the ASAIO.

Export to EndNote